{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T18:06:01Z","timestamp":1780423561376,"version":"3.54.1"},"reference-count":48,"publisher":"Impact Journals, LLC","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2014,11,30]]},"DOI":"10.18632\/oncotarget.2563","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T23:36:57Z","timestamp":1442360217000},"page":"11133-11142","source":"Crossref","is-referenced-by-count":93,"title":["The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canal"],"prefix":"10.18632","volume":"5","author":[{"given":"Cathy","family":"Eng","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J.","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Nancy You","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prajnan","family":"Das","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Rodriguez-Bigas","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xing","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Nicolas","family":"Vauthey","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane E.","family":"Rogers","sequence":"additional","affiliation":[{"name":"Division of Pharmacy, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aki","family":"Ohinata","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Pathak","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salil","family":"Sethi","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan K.","family":"Phillips","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher H.","family":"Crane","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Wolff","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2014,11,14]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Jemal","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/1097-0142(19840701)54:1<114::AID-CNCR2820540124>3.0.CO;2-P","article-title":"Carcinoma of the anal canal. A clinical and pathologic study of 188 cases","volume":"54","author":"Spencer","year":"1984","journal-title":"Cancer"},{"key":"3","first-page":"viii","article-title":"Chemotherapy and radiation of anal canal cancer: the first approach","volume":"13","author":"Minsky","year":"2004","journal-title":"Surg Oncol Clin N Am"},{"key":"4","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","article-title":"Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin","volume":"30","author":"Willett","year":"2012","journal-title":"J Clin Oncol"},{"key":"5","article-title":"The pattern and timing of disease recurrence in squamous cancer of the anus: Mature results from the NCRI ACT II trial","volume":"30","author":"Ledermann","year":"2012","journal-title":"J Clin Oncol"},{"key":"6","article-title":"Cisplatin (C) based chemoradiation (CXRT) for locally advanced squamous cell carcinoma (SCCA) of the anal canal (AC): A 20-year perspective","volume":"29","author":"Crane","year":"2011","journal-title":"J Clin Oncol"},{"key":"7","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s11864-009-0103-7","article-title":"Treatment options in metastatic squamous cell carcinoma of the anal canal","volume":"9","author":"Pathak","year":"2008","journal-title":"Curr Treat Options Oncol"},{"key":"8","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00384-008-0467-3","article-title":"Activity of paclitaxel in metastatic squamous anal carcinoma","volume":"23","author":"Alcindor","year":"2008","journal-title":"Int J Colorectal Dis"},{"key":"9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10637-006-7667-x","article-title":"Phase II study of mitomycin-C, adriamycin, cisplatin (MAP) and bleomycin-CCNU in patients with advanced cancer of the anal canal: an eastern cooperative oncology group study E7282","volume":"24","author":"Haller","year":"2006","journal-title":"Invest New Drugs"},{"key":"10","first-page":"4637","article-title":"Single-agent paclitaxel in advanced anal cancer after failure of cisplatin and 5-fluorouracil chemotherapy","volume":"31","author":"Fakih","year":"2011","journal-title":"Anticancer Res"},{"key":"11","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","article-title":"Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial","volume":"299","author":"Willett","year":"2008","journal-title":"JAMA"},{"key":"12","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","article-title":"Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups","volume":"15","author":"Pierart","year":"1997","journal-title":"J Clin Oncol"},{"key":"13","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1200\/JCO.2008.16.2339","article-title":"Induction therapy for poor-prognosis anal canal carcinoma: a phase II study of the cancer and Leukemia Group B (CALGB 9281)","volume":"26","author":"Mayer","year":"2008","journal-title":"J Clin Oncol"},{"key":"14","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00000421-199312000-00017","article-title":"Cisplatin and 5-fluorouracil as salvage therapy for recurrent metastatic squamous cell carcinoma of the anal canal","volume":"16","author":"Pazdur","year":"1993","journal-title":"Am J Clin Oncol"},{"key":"15","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/1097-0142(20010801)92:3<642::AID-CNCR1365>3.0.CO;2-Z","article-title":"Paclitaxel, carboplatin, and long-term continuous infusion of 5-fluorouracil in the treatment of advanced squamous and other selected carcinomas: results of a Phase II trial","volume":"92","author":"Greco","year":"2001","journal-title":"Cancer"},{"key":"16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0936-6555(05)80699-5","article-title":"Response of metastatic anal carcinoma to single agent carboplatin","volume":"5","author":"Glees","year":"1993","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","article-title":"Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival","volume":"11","author":"Ang","year":"2010","journal-title":"Lancet Oncol"},{"key":"18","first-page":"300","article-title":"Phase II study of combination bleomycin, vincristine and high-dose methotrexate (BOM) with leucovorin rescue in advanced squamous cell carcinoma of the anal canal","volume":"15","author":"Mittelman","year":"1985","journal-title":"Cancer Chemother Pharmacol"},{"key":"19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0002-9343(89)80702-8","article-title":"Combination of cisplatin plus fluoropyrimidine chemotherapy effective against liver metastases from carcinoma of the anal canal","volume":"87","author":"Wallace","year":"1989","journal-title":"Am J Med"},{"key":"20","first-page":"861","article-title":"5-Fluorouracile and cisplatinum combination chemotherapy for metastatic squamous-cell anal cancer","volume":"86","author":"Eschwege","year":"1999","journal-title":"Bull Cancer"},{"key":"21","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1093\/annonc\/mdt396","article-title":"DCF (docetaxel, cisplatin and 5-fluorouracil) chemotherapy is a promising treatment for recurrent advanced squamous cell anal carcinoma","volume":"24","author":"Borg","year":"2013","journal-title":"Ann Oncol"},{"key":"22","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1245\/s10434-007-9467-8","article-title":"Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center analysis","volume":"14","author":"Curley","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"23","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/jnci\/djr076","article-title":"Cancer Burden in the HIV-Infected Population in the United States","volume":"103","author":"Engels","year":"2011","journal-title":"JNCI"},{"key":"24","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1023\/A:1008279503428","article-title":"Paclitaxel by three-hour infusion and carboplatin in advanced carcinoma of nasopharynx and other sites of the head and neck. A phase II study conducted by the Hellenic Cooperative Oncology Group","volume":"8","author":"Daniilidis","year":"1997","journal-title":"Ann Oncol"},{"key":"25","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1200\/JCO.2001.19.13.3210","article-title":"Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non\u2014small-cell lung cancer: a Southwest Oncology Group trial","volume":"19","author":"Gandara","year":"2001","journal-title":"J Clin Oncol"},{"key":"26","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1200\/JCO.2005.01.057","article-title":"Randomized Phase III Evaluation of Cisplatin Plus Fluorouracil Versus Cisplatin Plus Paclitaxel in Advanced Head and Neck Cancer (E1395): An Intergroup Trial of the Eastern Cooperative Oncology Group","volume":"23","author":"Forastiere","year":"2005","journal-title":"J Clin Oncol"},{"key":"27","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1200\/JCO.2005.10.021","article-title":"Randomized Phase III Trial of Cisplatin With or Without Topotecan in Carcinoma of the Uterine Cervix: A Gynecologic Oncology Group Study","volume":"23","author":"Fiorica","year":"2005","journal-title":"J Clin Oncol"},{"key":"28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1006\/gyno.1996.0059","article-title":"Cisplatin\/5-fluorouracil treatment of recurrent cervical carcinoma: a phase II study with long-term follow-up","volume":"60","author":"Kristensen","year":"1996","journal-title":"Gynecol Oncol"},{"key":"29","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/annonc\/mdl265","article-title":"Cytotoxic chemotherapy for advanced or recurrent cervical cancer","volume":"17","author":"Lainakis","year":"2006","journal-title":"Ann Oncol"},{"key":"30","unstructured":"National Cancer Institute: PDQ\u00ae Anal Cancer Prevention. Bethesda, MD, National Cancer Institute. Date last modified 09\/19\/2014. Available at: http:\/\/cancer.gov\/cancertopics\/pdq\/prevention\/anal\/HealthProfessional Accessed 02\/21\/2014."},{"key":"31","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Rowinsky","year":"2006","journal-title":"N Engl J Med"},{"key":"32","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1200\/JCO.2009.21.9618","article-title":"Cetuximab and first-line taxane\/carboplatin chemotherapy in advanced non-small-cell lung cancer: results of the randomized multicenter phase III trial BMS099","volume":"28","author":"Woytowitz","year":"2010","journal-title":"J Clin Oncol"},{"key":"33","unstructured":"http:\/\/clinicaltrials.gov\/show\/NCT00324415. 2013. Cisplatin, Fluorouracil, Cetuximab, and Radiation Therapy in Treating Patients With HIV and Stage I, Stage II, or Stage III Anal Cancer."},{"key":"34","unstructured":"Clinicaltrials.gov. 2013. NCT00316888: Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Anal Cancer."},{"key":"35","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1002\/ijc.25625","article-title":"Human papillomavirus and survival in patients with base of tongue cancer","volume":"128","author":"Munck-Wikland","year":"2011","journal-title":"Int J Cancer"},{"key":"36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Gillison","year":"2010","journal-title":"N Engl J Med"},{"key":"37","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1007\/s10620-009-0812-6","article-title":"Molecular biomarkers correlate with disease-free survival in patients with anal canal carcinoma treated with chemoradiation","volume":"55","author":"Rashid","year":"2010","journal-title":"Dig Dis Sci"},{"key":"38","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1200\/JCO.2010.29.2904","article-title":"Prognostic Significance of p16INK4A and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial","volume":"28","author":"McArthur","year":"2010","journal-title":"J Clin Oncol"},{"key":"39","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1093\/annonc\/mdq210","article-title":"p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters","volume":"21","author":"Terracciano","year":"2010","journal-title":"Ann Oncol"},{"key":"40","article-title":"Human Papillomavirus is Associated with Unique Clinicopathologic Features in Patients with Metastatic Squamous Cell Carcinoma of the Anal Canal","volume":"32","author":"Eng","year":"2014","journal-title":"J Clin Oncol"},{"key":"41","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/annonc\/mdt574","article-title":"Impact of tumor HPV status on outcome in patients with recurrent and\/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial","volume":"25","author":"Licitra","year":"2014","journal-title":"Ann Oncol"},{"key":"42","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","article-title":"Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer","volume":"359","author":"Schueler","year":"2008","journal-title":"N Engl J Med"},{"key":"43","doi-asserted-by":"crossref","first-page":"F12","DOI":"10.1016\/j.vaccine.2012.07.055","article-title":"Global burden of human papillomavirus and related diseases","volume":"30","author":"Franceschi","year":"2012","journal-title":"Vaccine"},{"key":"44","first-page":"535","article-title":"Anal cancers among HIV-infected persons: HAART is not slowing rising incidence","volume":"24","author":"Agan","year":"2009","journal-title":"AIDS"},{"key":"45","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/QAI.0b013e3181b327ca","article-title":"A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals","volume":"52","author":"Poole","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"46","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1086\/597307","article-title":"The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV\u2212naive women aged 16-26 years","volume":"199","author":"Ferris","year":"2009","journal-title":"J Infect Dis"},{"key":"47","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","article-title":"Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial","volume":"369","author":"Limson","year":"2007","journal-title":"Lancet"},{"key":"48","unstructured":"Clinicaltrials.gov. 2014. International Multicentre Study in Advanced Anal Cancer Comparing Cisplatin Plus 5 FU vs Carboplatin Plus Weekly Paclitaxel (InterAACT)."}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.2563","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T21:20:16Z","timestamp":1589404816000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.2563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,14]]},"references-count":48,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2014,11,30]]}},"alternative-id":["2563","25373735"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.2563","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,14]]}}}